TransMedics Group, Inc. (TMDX)

TransMedics Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	531.29	441.54	241.62	93.46	30.26	25.64
Revenue Growth (YoY)	48.09%	82.74%	158.53%	208.83%	18.03%	8.62%
Cost of Revenue	213.62	179.46	87.53	28.19	9.1	9
Gross Profit	317.68	262.08	154.09	65.27	21.16	16.64
Selling, General & Admin	177.27	168.62	117.55	69.9	38.28	24.19
Research & Development	63.82	55.97	36.06	26.81	22.3	18.83
Operating Expenses	241.1	224.59	153.61	96.71	60.59	43.02
Operating Income	76.58	37.5	0.49	-31.44	-39.43	-26.38
Interest Expense	-14.13	-14.41	-10.79	-3.73	-3.87	-3.99
Interest & Investment Income	11	13.4	12.5	-	-	-
Currency Exchange Gain (Loss)	2.1	0.7	0.3	-	-1	1
Other Non Operating Income (Expenses)	-1.46	-1.41	0.05	-0.43	0.12	0.65
EBT Excluding Unusual Items	74.09	35.78	2.54	-35.59	-44.18	-28.72
Merger & Restructuring Charges	-	-	-2	-	-	-
Other Unusual Items	-	-	-	-0.58	-	-
Pretax Income	74.09	35.78	-26.67	-36.17	-44.18	-28.72
Income Tax Expense	2.43	0.32	-1.64	0.07	0.04	0.03
Net Income	71.66	35.46	-25.03	-36.23	-44.22	-28.75
Net Income to Common	71.66	35.46	-25.03	-36.23	-44.22	-28.75
Shares Outstanding (Basic)	34	33	33	30	28	25
Shares Outstanding (Diluted)	38	35	33	30	28	25
Shares Change (YoY)	11.94%	8.30%	10.02%	7.02%	11.80%	73.91%
EPS (Basic)	2.13	1.07	-0.77	-1.23	-1.60	-1.16
EPS (Diluted)	2.02	1.01	-0.77	-1.23	-1.60	-1.16
Free Cash Flow	17.35	-80.94	-164.88	-57.72	-32.38	-30.72
Free Cash Flow Per Share	0.46	-2.30	-5.07	-1.95	-1.17	-1.24
Gross Margin	59.79%	59.36%	63.77%	69.84%	69.92%	64.88%
Operating Margin	14.41%	8.49%	0.20%	-33.64%	-130.29%	-102.91%
Profit Margin	13.49%	8.03%	-10.36%	-38.77%	-146.11%	-112.13%
Free Cash Flow Margin	3.27%	-18.33%	-68.24%	-61.76%	-107.01%	-119.82%
EBITDA	100.3	57.25	8.66	-27.96	-37.61	-24.81
EBITDA Margin	18.88%	12.97%	3.58%	-29.92%	-124.28%	-96.75%
D&A For EBITDA	23.73	19.76	8.18	3.48	1.82	1.58
EBIT	76.58	37.5	0.49	-31.44	-39.43	-26.38
EBIT Margin	14.41%	8.49%	0.20%	-33.64%	-130.29%	-102.91%
Effective Tax Rate	3.28%	0.88%	-	-	-	-
Revenue as Reported	531.29	441.54	241.62	93.46	30.26	25.64

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q